Skip to main content

Table 4 Summary of adverse events (AE)

From: Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation

 

Snus group, n = 158 (%)

Placebo group, n = 161 (%)

Any AE

42 (26.6)

26 (16.1)

SAE

1 (0.6)

0

AE leading to discontinuation of study treatment

2 (1.3)

0

Treatment-related AE

30 (19.0)

18 (11.2)

  1. SAE: serious adverse event, Treatment-related: relation to allocated study treatment considered by the trialist to be possible, probable, or definite,